Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study
PaperCitations, authors & open-access status
Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 106 citations, 2023 year and closed oa status.
106
Citations
2023
Year
closed
OA Status